| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.017 | 0.9 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |